Healthcare

Whole Exome Sequencing Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Whole Exome Sequencing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Whole Exome Sequencing Market:

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

According to The Business Research Company’s Whole Exome Sequencing Global Market Report 2024, The whole exome sequencing market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to genomic research advancements, precision medicine trends, rare disease diagnosis, pharmaceutical and biotech applications, declining sequencing costs.

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2028 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to expanding applications in oncology, integration in clinical diagnostics, rise in genetic testing demand, population genomics initiatives, emergence of gene therapies. Major trends in the forecast period include enhanced clinical utility and adoption, decreasing costs of sequencing, focus on data security and privacy, integration with electronic health records, advances in single-cell sequencing.

Increasing HIV (human immunodeficiency virus) prevalence is expected to propel the growth of the whole exome sequencing market going forward. HIV refers to a virus that targets the immune system of the body. Whole exome sequencing is used to provide genomic structures of viruses that are useful for personalized treatment and vaccine designs for HIV. For instance, in April 2023, according to the World Health Organization, a Switzerland-based United Nations agency, HIV remains a major global public health issue, with 38.4 million patients globally in 2021 and 650 000 deaths from HIV-related causes. Therefore, the increasing HIV prevalence is driving the growth of the whole exome sequencing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

The whole exome sequencing market covered in this report is segmented –

1) By Product: Systems, Kits, Services

2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research

4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users

Innovative diagnostic techniques are a key trend gaining popularity in the whole exome sequencing market. Companies operating in the whole exome sequencing market are working on new product innovations to sustain their position in the market. For instance, in February 2023, Illumina Inc., a US-based biotechnology company launched NovaSeqX Plus, the most powerful sequencing technology, delivering an unprecedented combination of high throughput and accuracy and featuring streamlined informatics, sustainability advancements, and economical sequencing. The innovations built into the NovaSeq X Plus systems have the power to generate tens of thousands of whole genomes per year, maximize productivity, and minimize turnaround time.

The whole exome sequencing market report table of contents includes: